Journal of Medicinal Chemistry
Volume 40, Issue 25 (December 5, 1997)
Copyright © 1997
American Chemical Society
3991-3991 | Accelerated Electronic Publication
|
3992-3996 | A Modular Lymphographic Magnetic Resonance Imaging Contrast Agent: Contrast Enhancement with DNA Transfection Potential
|
3997-4005 | Examination of the Role of the Acidic Hydrogen in Imparting Selectivity of 7-(Aminosulfonyl)-1,2,3,4-tetrahydroisoquinoline (SK&F 29661) Toward Inhibition of Phenylethanolamine N-Methyltransferase vs the  2-Adrenoceptor1a
|
4006-4012 | Screening Solution-Phase Combinatorial Libraries Using Pulsed Ultrafiltration/Electrospray Mass Spectrometry
|
4013-4018 | Intensely Cytotoxic Anthracycline Prodrugs: Glucuronides
|
4019-4025 | 1-[1-(2-Benzo[b]thiopheneyl)cyclohexyl]piperidine Hydrochloride (BTCP) Yields Two Active Primary Metabolites in Vitro: Synthesis, Identification from Rat Liver Microsome Extracts, and Affinity for the Neuronal Dopamine Transporter
|
4026-4029 | (Aryloxy)alkylamines as Selective Human Dopamine D4 Receptor Antagonists: Potential Antipsychotic Agents
|
4030-4052 | Design and Synthesis of Benzoic Acid Derivatives as Influenza Neuraminidase Inhibitors Using Structure-Based Drug Design
|
4053-4068 | Effect of Plasma Protein Binding on in Vivo Activity and Brain Penetration of Glycine/NMDA Receptor Antagonists
|
4069-4078 | Cationic Lipid-Mediated Gene Delivery to Murine Lung: Correlation of Lipid Hydration with in Vivo Transfection Activity
|
4079-4088 | Nonsymmetrically Substituted Cyclic Urea HIV Protease Inhibitors
|
4089-4102 | A Strategy for the Incorporation of Water Molecules Present in a Ligand Binding Site into a Three-Dimensional Quantitative Structure-Activity Relationship Analysis
|
4103-4112 | Identification of Novel Farnesyl Protein Transferase Inhibitors Using Three-Dimensional Database Searching Methods
|
4113-4135 | Peptidomimetic Inhibitors of the Human Cytomegalovirus Protease
|
4136-4145 | Assessment of Solvation Effects on Calculated Binding Affinity Differences: Trypsin Inhibition by Flavonoids as a Model System for Congeneric Series.
|
4146-4153 | Synthesis and Pharmacological Evaluation of Triflate-Substituted Analogues of Clozapine: Identification of a Novel Atypical Neuroleptic
|
4154-4159 | On the Conformation of Tiazofurin Analogues
|
4160-4160 | Current Directions in Radiopharmaceutical Research and Development. Edited by Stephen J. Mather. Kluwer Academic Publishers, Boston, MA. 1996. xvi + 237 pp. 16.5 × 24.5 cm. ISBN 0-7923-4254-2. $136.00.
|
4160-4160 | Circular Dichroism and Linear Dichroism Alison Rodger and Bengt Nordén. Oxford University Press, Oxford, U.K. 1997. x + 150 pp. 19.5 × 25 cm. ISBN 0-19-855897-X. $60.00.
|
4160-4161 | Glycopeptides and Related Compounds. Synthesis, Analysis, and Applications Edited by D. G. Large and C. D. Warren. Marcel Dekker, Inc., New York. 1997. xii + 767 pp. 18.5 × 26 cm. ISBN-0-8247-9531-8. $195.00.
|
4161-4161 | Handbook of Phase I/II Clinical Drug Trials Edited by John O'Grady and Peter H. Joubert. CRC Press, Boca Raton, FL. 1997. xii + 562 pp. 18.5 × 26 cm. ISBN 0-8493-9230-6. $149.95. [Full Article - PDF] |
4161-4161 | Methods in Molecular Biology. Volume 78. Antibacterial Peptide Protocols Edited by William S. Shafer. The Humana Press, Totowa, NJ. 1997. x + 259 pp. 15.5 × 23.5 cm. ISBN 0-89603-408-9. $74.50.
|
4161-4162 | List of MAK and BAT Values 1996 Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area Report No. 32. Deutsche Forschungsgemeinschaft. Authorized by H. Green. VCH Verlagsgesellschaft mbH, Weinheim, Germany. 1996. xxii + 180 pp. 17 × 24 cm. ISBN 3-527-27572-X. DM 64.00 (pbk).
|
4162-4162 | Landmarks in Gene Regulation Edited by D. S. Latchman. Portland Press Ltd., London. 1997. xii + 302 pp. 21 × 30 cm. ISBN 1-85578-109-3. $34.00 (pbk).
|
4162-4162 | Controlled Drug Delivery. Challenges and Strategies Edited by Kinam Park. American Chemical Society, Washington, D.C. 1997. xvii + 629 pp. 20 × 24 cm. ISBN 0-8412-3418-3. $149.95.
|
4162-4163 | High Throughput Screening. The Discovery of Bioactive Substances, 1997 Edited by John P. Devlin. Marcel Dekker, Inc., New York. 1997. xxiv + 673 pp. 18.5 × 26 cm. ISBN 0-8247-0067-8. $165.00.
|
4163-4163 | Cytochromes P450. Structure, Function, and Mechanism By David F. Lewis. Taylor & Francis, London and Bristol, PA. 1996. xxi + 348 pp. 17.5 × 25 cm. ISBN 0-7484-0443-0. $150.00.
|
4163-4163 | Ligand-Receptor Energetics. A Guide for the Perplexed By Irving M. Klotz. John Wiley & Sons, Inc., New York. 1997. xi + 170 pp. 15.5 × 23 cm. ISBN 0-471-17626-5. $44.95.
|
4163-4164 | Molecular Mechanics Across Chemistry By Anthony K. Rappé and Carla J. Casewit. University Science Books, Susalito, CA. 1997. xii + 444 pp. 18.5 × 26 cm. ISBN 0-935702-77-6. $56.50.
|
4164-4164 | Cancer Therapeutics: Experimental and Clinical Agents Edited by Beverly A. Teicher. Humana Press, Totowa, NJ. 1996. x + 451 pp. 18 × 26 cm. ISBN 0-89603-460-7. $125.00.
|
4164-4165 | Antidepressants. New Pharmacological Strategies Edited by P. Skolnick. Humana Press, Totowa, NJ. 1997. x + 257 pp. 18.5 × 26 cm. ISBN-0-89603-469-0. $99.50.
|
4165-4165 | NMR Spectroscopy and Its Application to Biomedical Research Edited by Susanta K. Sarkar. Elsevier Science, Amsterdam, The Netherlands. 1996. xviii + 387 pp. 15.5 × 23 cm. ISBN 0-444-89410-1. $250.00.
|
4165-4166 | Comprehensive Heterocyclic Chemistry II Edited by A. R. Katritzky, C. W. Rees, and E. F. V. Scriven. Pergamon Press, Elsevier Science, Ltd., Tarrytown, NY. 1996. 12 Volumes: Vol. 1A, xxvii + 505 pp; Vol. 1B, 860 pp; Vol. 2, xiii + 1102 pp; Vol. 3, xiii + 932 pp; Vol. 4, xxiii + 1006 pp; Vol. 5, xxiii + 794 pp; Vol. 6, xxiii + 1307 pp; Vol. 7, xxiii + 1044 pp; Vol. 8, xv + 1326 pp; Vol. 9, xvii + 1146 pp; Vol. 10, xix + 729 pp; Vol. 11, xi + 596 pp. 19.5 × 28 cm. ISBN 0-08-042724-3; 0-08-042725-1; 0-08-042726-X; 0-08-042727-8; 0-08-042728-6; 0-08-042729-4; 0-08-042730-8; 0-08-042731-6; 0-08-042732-4; 0-08-042965-3; 0-08-042987-4. $6345.00 (set).
|
4166-4166 | Books of Interest [Full Article - PDF] |
4166-4167 | [Full Article - PDF] |
4167-4167 | [Full Article - PDF] |
4167-4167 | [Full Article - PDF] |
4168-4168 | Reliability of CoMFA Models: Effects of Data Scaling and Variable Selection using a Set of Human Synovial Fluid Phospholipase A2 InhibitorsPrediction of Drug Binding Affinities by Comparative Binding Energy Analysis
|